These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15208609)

  • 1. Lowell and Franklin on double-blind hyposensitization therapy for ragweed hay fever: the people.
    Cohen SG
    J Allergy Clin Immunol; 2004 Jun; 113(6):1227-31. PubMed ID: 15208609
    [No Abstract]   [Full Text] [Related]  

  • 2. Lowell and Franklin on double-blind hyposensitization therapy for ragweed hay fever: the paper.
    Dworetzky M
    J Allergy Clin Immunol; 2004 Jun; 113(6):1231-3. PubMed ID: 15208610
    [No Abstract]   [Full Text] [Related]  

  • 3. HYPOSENSITIZATION STUDIES WITH A PURIFIED DWARF RAGWEED FRACTION.
    KAPLAN MA; SPITZER RH; GUTMAN AA; KALAYIL PK
    Ann Allergy; 1963 Sep; 21():494-504. PubMed ID: 14062371
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new desensitization agent in the treatment of ragweed-induced seasonal allergic rhinitis (hay fever) in children: MRTA (modified ragweed tyrosine adsorbate)].
    Weisnagel J
    Union Med Can; 1979 Jun; 108(6):685-90. PubMed ID: 116408
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of hyposensitization therapy in ragweed hay-fever in children.
    Fontana VJ; Holt LE; Mainland D
    JAMA; 1966 Mar; 195(12):985-92. PubMed ID: 5952104
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic studies of ragweed-sensitive patients. II. Effect of specific hyposensitization therapy on hemagglutinating antibody titers.
    ARBESMAN CE; ROSE NR; KANTOR SZ
    J Allergy; 1960; 31():333-41. PubMed ID: 13794041
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of ragweed sublingual allergy immunotherapy tablets in adults with allergic rhinoconjunctivitis.
    Nayak AS; Atiee GJ; Dige E; Maloney J; Nolte H
    Allergy Asthma Proc; 2012; 33(5):404-10. PubMed ID: 23026182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.
    Casale TB; Busse WW; Kline JN; Ballas ZK; Moss MH; Townley RG; Mokhtarani M; Seyfert-Margolis V; Asare A; Bateman K; Deniz Y;
    J Allergy Clin Immunol; 2006 Jan; 117(1):134-40. PubMed ID: 16387596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic studies of ragweed-sensitive patients. III. Clinical aspects: the relationship of reagin and hemagglutinating antibody titers to results of hyposensitization therapy.
    ARBESMAN CE; KANTOR SZ; RAPP D; ROSE NR
    J Allergy; 1960; 31():342-50. PubMed ID: 13794038
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical effects of ragweed antigen emulsion. A double-blind study.
    FRIEDLAENDER S; FRIEDLAENDER AS
    J Allergy; 1962; 33():412-22. PubMed ID: 13895224
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen.
    Patel P; Holdich T; Fischer von Weikersthal-Drachenberg KJ; Huber B
    J Allergy Clin Immunol; 2014 Jan; 133(1):121-9.e1-2. PubMed ID: 23870670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis.
    Bowen T; Greenbaum J; Charbonneau Y; Hebert J; Filderman R; Sussman G; Del Carpio J; Gold M; Keith P; Moote W; Cecchetto S; Cecchetto O; Sharp D; Broutin O; André C
    Ann Allergy Asthma Immunol; 2004 Nov; 93(5):425-30. PubMed ID: 15562880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyposensitization in ragweed pollinosis.
    Speer F; Carrasco LC
    Ann Allergy; 1976 Dec; 37(6):391-7. PubMed ID: 999058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of desensitization therapy in hay fever.
    Dieges PH
    Acta Otorhinolaryngol Belg; 1979; 33(4):522-7. PubMed ID: 395812
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults.
    Creticos PS; Maloney J; Bernstein DI; Casale T; Kaur A; Fisher R; Liu N; Murphy K; Nékám K; Nolte H
    J Allergy Clin Immunol; 2013 May; 131(5):1342-9.e6. PubMed ID: 23622121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromidrosis associated with ragweed hyposensitization.
    HAYDEN HC
    Ann Allergy; 1946; 4(5):372. PubMed ID: 20273580
    [No Abstract]   [Full Text] [Related]  

  • 17. Sublingual swallow immunotherapy in the new world.
    Norman PS
    Ann Allergy Asthma Immunol; 2004 Nov; 93(5):405-6. PubMed ID: 15562876
    [No Abstract]   [Full Text] [Related]  

  • 18. TREATMENT OF RAGWEED HAY FEVER WITH ALUM PRECIPITATED PYRIDINE COMPLEX EXTRACTS.
    TUFT L
    Clin Med (Northfield); 1964 Mar; 71():459-70. PubMed ID: 15446130
    [No Abstract]   [Full Text] [Related]  

  • 19. THE NATURAL HISTORY OF RAGWEED HAY FEVER; A TWENTY-YEAR STUDY OF 120 PATIENTS.
    RACKEMANN FM; LAMSA T
    J Allergy; 1965; 36():258-64. PubMed ID: 14279748
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
    Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
    N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.